Back
NovaBay Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
NBY
NovaBay Pharmaceuticals
Last Price:
$0.68
Seasonality Move:
-19.9%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Sell |
| 20-day SMA: | 0.62 | Buy |
| 50-day SMA: | 0.6 | Buy |
| 200-day SMA: | 0.62 | Buy |
| 8-day EMA: | 0.55 | Buy |
| 20-day EMA: | 0.34 | Buy |
| 50-day EMA: | 0.16 | Buy |
| 200-day EMA: | 0.04 | Buy |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 54.86 | Buy |
| Chaikin Money Flow: | 242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.58 - 0.66) | Buy |
| Bollinger Bands (100): | (0.55 - 0.63) | Buy |
NovaBay Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.65 while NBY 8-day simple moving average is 0.67, which is a Sell signal.
-
The stock price of NBY is 0.65 while NovaBay Pharmaceuticals 20-day SMA is 0.62, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.60 while NBY share price is 0.65, making it a Buy technically.
-
NBY stock price is 0.65 and NovaBay Pharmaceuticals 200-day simple moving average is 0.62, creating a Buy signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.65. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.8M
Price in USD:
0.65
Share Volume:
23.7K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
2.26
52-Week Low:
0.36
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.65 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.65 while NBY 8-day exponential moving average is 0.55, which is a Buy signal.
-
The stock price of NBY is 0.65 while NovaBay Pharmaceuticals 20-day EMA is 0.34, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.16 while NBY share price is 0.65, making it a Buy technically.
-
NBY stock price is 0.65 and NovaBay Pharmaceuticals 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting NovaBay Pharmaceuticals is a Buy
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 54.86, which suggest NovaBay Pharmaceuticals is overbought
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.58 - 0.66), which suggest NovaBay Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.55 - 0.63), which suggest NovaBay Pharmaceuticals is a Buy
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.